Nymox Pharmaceutical Corp (NYMXF)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $0.04
- As of
Kresmion compiles this page from NYMXF's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
NYMOX PHARMACEUTICAL CORP (NYMXF): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 20-F filed 2026-09-14.
See the full NYMXF dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for NYMXF on one page. Preview it with sample data, then open it live with a free account.
Preview the NYMXF dossierActive events for NYMXF
- mediumEarnings above estimates
Q3-2013: Beat consensus by 43.5% - EPS $-0.03 vs $-0.0531 estimate
- mediumEarnings above estimates
Q4-2013: Beat consensus by 43.5% - EPS $-0.03 vs $-0.0531 estimate
- mediumEarnings above estimates
Q4-2013: Beat consensus by 24.7% - EPS $-0.04 vs $-0.0531 estimate
FREE, NO ACCOUNT
Every event on NYMXF, as it fires
New filings, 13F moves and cross asset events on NYMXF land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Historical quarters remain available above.
Recent SEC filings, NYMXF
- 20-FSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 20-FSEC EDGAR ↗
Related tickers
Follow NYMXF on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to NYMXF for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.